The Korean Pharmaceutical and Bio Association is set to create a platform for sharing next-generation antibody-drug conjugate (ADC) technology and collaboration strategies.
The association announced on August 11 that it will hold the 10th 'K-SPACE STATION' on the 20th at its headquarters in Seocho-gu, Seoul.
K-SPACE STATION is a technology exchange event aimed at revitalizing the open innovation ecosystem by sharing and exploring the application of fundamental and cutting-edge technologies from industry, academia, and research.
As global pharmaceutical giants actively adopt ADC technology, the field has emerged as a key investment target. With fierce competition among major domestic pharmaceutical companies in ADC development, the upcoming event will focus on sharing next-generation ADC development technologies and manufacturing and analysis platforms.
The detailed program includes presentations such as 'Beyond Current ADCs: TrioR's Next-Generation ADC Development Strategy' by Park Jo-hae, Head of TrioR, and 'De-Risking ADC Development through Integrated CDAMO Solutions' by Cho Ik-hyun, Vice President of Proteum Science. Following the presentations, a networking session will allow participants to discuss collaboration opportunities.
Participants will include industry professionals interested in the technologies presented and collaboration in the ADC field. Registration is available through Google Forms until the 14th, and due to limited parking, public transportation is recommended.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.